Jacob C. Easaw

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley, Makoto Ueno, Changhoon Yoo et al. · The Lancet · 2023 · 891 citations · Full text

Urology, Surgical Oncology, Gastrointestinal Oncology +5

Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study

James Perry, Karl Bélanger, Warren Mason et al. · Journal of Clinical Oncology · 2010 · 380 citations

A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation

Brian Thiessen, Clinton F. Stewart, Ming‐Sound Tsao et al. · Cancer Chemotherapy and Pharmacology · 2009 · 200 citations

Oncology, Molecular Correlation, Medicine +10

Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma

Xueqing Lun, J. Connor Wells, Natalie Grinshtein et al. · Clinical Cancer Research · 2016 · 196 citations

Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma

Linda Dirven, Andrew A. Kanner, Gitit Lavy-Shahaf et al. · JAMA Oncology · 2018 · 180 citations · Full text